David C Dvorak Invests $5 Million in THINK Surgical
David C Dvorak had a successful 16-year career at Zimmer Biomet Holdings, Inc. where he most recently held the position of president and chief executive officer for a decade.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
David C Dvorak had a successful 16-year career at Zimmer Biomet Holdings, Inc. where he most recently held the position of president and chief executive officer for a decade.
Doceree reports the financing accelerates company’s global growth and development of its platform to enrich HCP messaging solutions on endemic and point-of-care networks for life sciences companies.
Aspen Surgical Products CEO Jason Krieser said, “This transaction represents an excellent return for our original investors, while empowering our Aspen Surgical organization to continue to progress in our mission of improving safety and efficiency for clinicians at an even faster rate.”